The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer

Estrogen receptor positive breast neoplasias represent over 70% of diagnosed breast cancers. Depending on the stage at which the tumor is detected, HER2 status and genomic risk, endocrine therapy is combined with either radio, chemo and/or targeted therapy. A growing amount of evidence supports the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Endocrinol (Lausanne)
Huvudupphovsmän: Diaz Bessone, María Inés, Gattas, María José, Laporte, Tomás, Tanaka, Max, Simian, Marina
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2019
Ämnen:
Endocrinology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6694443/
https://ncbi.nlm.nih.gov/pubmed/31440208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00547
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk